Becton, Dickinson and Company (BDX)
-NYSE 101.11 
0.01(0.01%) 03:42 SGT - Nasdaq Real Time Price
| Prev Close: | 101.12 |
|---|
| Open: | 101.16 |
|---|
| Bid: | 101.10 x 200 |
|---|
| Ask: | 101.11 x 200 |
|---|
| 1y Target Est: | 97.00 |
|---|
| Beta: | 0.83 |
|---|
| Next Earnings Date: | 2-Aug-13 |
|---|
| Day's Range: | 101.08 - 101.89 |
|---|
| 52wk Range: | 71.56 - 102.42 |
|---|
| Volume: | 586,042 |
|---|
| Avg Vol (3m): | 1,129,020 |
|---|
| Market Cap: | 19.64B |
|---|
| P/E (ttm): | 13.47 |
|---|
| EPS (ttm): | 7.51 |
|---|
| Div & Yield: | 1.98 (1.90%) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- THOR Downgraded to UnderperformZacks(Wed, 02:00 SGT)
- BD Board Declares DividendPR Newswire(Tue, 21 May)
- FDA Nod for Thoratec ControllerZacks(Tue, 21 May)
- PKI Downgraded to UnderperformZacks(Tue, 21 May)
- July Options Now Available For Becton, Dickinson And Co. (BDX)at TheStreet(Tue, 21 May)
- The Top 35 Dividend Champions With Regard To Long-Term Stock Price Appreciationat Seeking Alpha(Mon, 20 May)
- Diversify Into Singapore Dollars And Get 4% Yields With High Quality Baa3 Rated Bondsat Seeking Alpha(Sat, 18 May)
- 4 Stocks Driving The Health Services Industry Higherat TheStreet(Sat, 18 May)
- Wall Street Transcript Interview with Mark W. Oelschlager, Portfolio Manager at Oak Associates, Ltd.: A Health Sciences Fund with a Long-Term FocusWall Street Transcript(Fri, 17 May)
- Zacks Industry Outlook Highlights: Life Technologies, Thermo Fisher Scientific, Bayer, Conceptus and Becton, Dickinson and Co.Zacks(Thu, 16 May)
Key Statistics
| Forward P/E (1 yr): | 16.10 |
|---|
| P/S (ttm): | 2.50 |
|---|
| Ex-Dividend Date: | 06-Mar-13 |
|---|
Analysts
| Annual EPS Est
(Sep-13)
: | 5.74 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.48 |
|---|
| Mean Recommendation*: | 2.9 |
|---|
| PEG Ratio (5 yr expected): | 1.97 |
|---|
Business Summary
Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide.
View More